07/31/2025
7:05 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2025
7:11 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/18/2025
3:48 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
3:10 PM | Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
3:18 PM | Alnylam Pharmaceuticals (Subject)
Greenstreet Yvonne (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2025
4:01 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
7:09 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
7:15 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/07/2025
10:51 AM | Alnylam Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
03/24/2025
4:00 PM | Alnylam Pharmaceuticals (Filer)
| Form DEFA14A | |
03/24/2025
4:02 PM | Alnylam Pharmaceuticals (Filer)
| Form ARS | |
Get the Latest News and Ratings for ALNY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/24/2025
3:40 PM | Alnylam Pharmaceuticals (Filer)
| Form DEF 14A | |
03/24/2025
3:13 PM | Alnylam Pharmaceuticals (Subject)
PYOTT DAVID E I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
3:16 PM | Alnylam Pharmaceuticals (Filer)
| Form PRE 14A | |
03/14/2025
3:16 PM | Alnylam Pharmaceuticals (Issuer)
SCHULMAN AMY W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:31 PM | Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:31 PM | Alnylam Pharmaceuticals (Issuer)
Tanguler Tolga (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:31 PM | Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:32 PM | Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
1:14 PM | Alnylam Pharmaceuticals (Subject)
Capital Research Global Investors (Filed by)
| Form SCHEDULE 13G | |
02/13/2025
7:31 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2025
7:09 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
3:01 PM | Alnylam Pharmaceuticals (Subject)
Garg Pushkal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
3:17 PM | Alnylam Pharmaceuticals (Subject)
SHARP PHILLIP A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
6:31 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
3:13 PM | Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:20 PM | Alnylam Pharmaceuticals (Issuer)
Fitzgerald Kevin Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:21 PM | Alnylam Pharmaceuticals (Issuer)
Tanguler Tolga (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:21 PM | Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:22 PM | Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:22 PM | Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:06 PM | Alnylam Pharmaceuticals (Subject)
Fitzgerald Kevin Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
9:34 AM | Alnylam Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
10/31/2024
7:10 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
7:22 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/03/2024
3:11 PM | Alnylam Pharmaceuticals (Issuer)
Hesslein Robert W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:01 PM | Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
4:10 PM | Alnylam Pharmaceuticals (Subject)
Greenstreet Yvonne (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
8:40 AM | Alnylam Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
